ARTICLE | Clinical News
Ketoprofen/omeprazole regulatory update
December 15, 2008 8:00 AM UTC
Meda AB (SSE:MEDA, Solna, Sweden) said the U.K. approved the company's ketoprofen/omeprazole combination product to treat pain and inflammation. The combination of an NSAID and a proton pump inhibito...